(Q39116353)

English

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

scientific article published on September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma (English)

1 reference

Europe PubMed Central

9 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ragde H

1

1 reference

Europe PubMed Central

9 September 2017

Elgamal AA

2

1 reference

Europe PubMed Central

9 September 2017

Snow PB

3

1 reference

Europe PubMed Central

9 September 2017

Brandt J

4

1 reference

Europe PubMed Central

9 September 2017

Bartolucci AA

5

1 reference

Europe PubMed Central

9 September 2017

Nadir BS

6

1 reference

Europe PubMed Central

9 September 2017

Korb LJ

7

1 reference

Europe PubMed Central

9 September 2017

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

83

1 reference

Europe PubMed Central

9 September 2017

989-1001

1 reference

Europe PubMed Central

9 September 2017

5

1 reference

Europe PubMed Central

9 September 2017

Frequency of residual neoplasm in the prostate following three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

The effect of dose on local control of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Anatomic localization of radioactive gold seeds of the prostate by computer-aided tomography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Value of computed tomography in interstitial 125I brachytherapy of prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostatorectal fistula associated with 125iodine seed radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Permanent interstitial implantation using palladium-103: the New York Medical College preliminary experience

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Radical prostatectomy and radical radiation therapy for clinical stages T1 to 2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen followup.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Patterns of care outcome studies: results of the national practice in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostate specific antigen following radiotherapy for local prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Impact of radical prostatectomy in the management of clinically localized disease.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Pathological stage is higher in older men with clinical stage B1 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C989%3A%3AAID-CNCR26%3E3.0.CO%3B2-Q

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39116353&oldid=1808152978"